OFA raises concern about the adequacy of the cost-benefit analysis completed as part of the Regulatory Impact Analysis Statement for the Front-of-Package (FOP) labeling consultation and Regulations amending certain regulations made under the Food and Drugs Act (Nutrition Symbols, Other Labelling Provisions, Partially Hydrogenated Oils and Vitamin D). OFA insists that a comprehensive review of the analysis be undertaken before this FOP proposal progresses any further.